Skip to main content

Silk Road Medical Inc

SILKDelisted Sep 17, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001397702

Silk Road Medical Inc was delisted on Sep 17, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 172 institutions reported holding it in 13F filings for Q2 2024, worth $1.03B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Silk Road Medical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Silk Road Medical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Silk Road Medical Inc
NameTitleLast reported holdingLast filingFilings, past year
Lasersohn Jack WDirector0Sep 18, 20240
Weatherman Elizabeth HDirector0Sep 18, 20240
Zurbay DonaldDirector0Sep 18, 20240
Klemz Kevin MEVP/Chief Legal Officer/Sec.0Sep 18, 20240
Anderson Rick DDirector0Sep 18, 20240
Ballinger Kevin J.Director0Sep 18, 20240
McKhann ChasChief Executive Officer0Sep 18, 20240
Buchanan Lucas W.COO & CFO0IndirectSep 18, 20240
Chou Tony M.Director0Sep 18, 20240
Davis Andrew S.Chief Commercial Officer0Sep 18, 20240
Ruedy RichardEVPClin&Reg.Affairs&QA0IndirectSep 18, 20240
Carino TanishaDirector0Sep 18, 20240
Jones Marie L.VP, Finance and CAO0Sep 18, 20240
Rogers Erica J.President and CEO267,988Sep 29, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 17, 2022 (view filing)Aug 152 daysBuchanan Lucas W.COO/CFOSSale−25.0K$48.46−$1.21M−12.2%179.1K after2 lots
Aug 15, 2022 (view filing)Aug 114 daysRogers Erica J.President and CEOSSale−10.0K$48.60−$486.0K−3.9%246.2K after
Aug 12, 2022 (view filing)Aug 10-122 daysBuchanan Lucas W.COO/CFOSSale−75.0K$47.81−$3.59M−28.1%191.8K after7 lots
Aug 9, 2022 (view filing)Aug 81 dayWeatherman Elizabeth HDirectorSSale−8.64K$49.91−$431.5K−3.8%220.8K after
Jul 25, 2022 (view filing)Jul 214 daysWeatherman Elizabeth HDirectorSSale−5.00K$41.91−$209.6K−2.1%229.5K after
Jul 13, 2022 (view filing)Jul 112 daysRogers Erica J.President and CEOSSale−30.0K$40.44−$1.21M−10.9%245.6K after
Jul 11, 2022 (view filing)Jul 83 daysWeatherman Elizabeth HDirectorSSale−10.0K$41.91−$419.1K−4.1%234.5K after
Apr 13, 2022 (view filing)Apr 112 daysRogers Erica J.President and CEOSSale−30.0K$43.37−$1.30M−10.9%245.6K after
Jan 13, 2022 (view filing)Jan 112 daysRogers Erica J.President and CEOSSale−10.0K$41.88−$418.8K−7.0%132.2K after
Dec 15, 2021 (view filing)Dec 132 daysRogers Erica J.President and CEOSSale−10.0K$40.95−$409.5K−7.0%132.2K after
Nov 30, 2021 (view filing)Nov 30Same dayRogers Erica J.President and CEOPPurchase+2.50K$41.30+$103.3K+1.9%132.2K after
Nov 17, 2021 (view filing)Nov 161 dayBuchanan Lucas W.COO/CFOSSale−10.0K$50.32−$503.2K−5.3%180.0K after
Nov 15, 2021 (view filing)Nov 114 daysRogers Erica J.President and CEOSSale−18.1K$50.62−$915.9K−12.2%129.7K after3 lots
Nov 2, 2021 (view filing)Nov 11 dayDavis Andrew S.Chief Commercial OfficerSSale−4.80K$60.96−$292.9K−6.4%70.3K after5 lots
Oct 29, 2021 (view filing)Oct 272 daysBuchanan Lucas W.COO/CFOSSale−10.0K$59.39−$593.9K−5.3%180.0K after2 lots
Oct 12, 2021 (view filing)Oct 111 dayRogers Erica J.President and CEOSSale−11.0K$55.73−$613.0K−7.7%132.0K after
Oct 5, 2021 (view filing)Oct 14 daysDavis Andrew S.Chief Commercial OfficerSSale−6.32K$53.90−$340.9K−8.3%70.3K after2 lots
Sep 29, 2021 (view filing)Sep 281 dayBuchanan Lucas W.COO/CFOSSale−10.0K$54.86−$548.6K−5.2%182.7K after
Sep 14, 2021 (view filing)Sep 131 dayRogers Erica J.President and CEOSSale−11.0K$57.32−$630.5K−7.7%132.0K after
Sep 3, 2021 (view filing)Sep 12 daysDavis Andrew S.Chief Commercial OfficerSSale−6.48K$59.71−$387.0K−8.4%70.3K after4 lots
Aug 31, 2021 (view filing)Aug 274 daysBuchanan Lucas W.COO/CFOSSale−10.0K$54.38−$543.8K−5.2%182.7K after2 lots
Aug 30, 2021 (view filing)Aug 273 daysRuedy RichardEVPClin&Reg.Affairs&QASSale−15.4K$55.00−$847.4K−11.6%117.4K after2 lots
Aug 12, 2021 (view filing)Aug 111 dayRogers Erica J.President and CEOSSale−11.0K$49.12−$540.3K−7.7%132.0K after
Aug 3, 2021 (view filing)Aug 21 dayDavis Andrew S.Chief Commercial OfficerSSale−6.32K$50.75−$320.9K−16.7%31.6K after2 lots
Jul 29, 2021 (view filing)Jul 281 dayBuchanan Lucas W.COO/CFOSSale−10.0K$44.91−$449.1K−5.1%186.8K after3 lots
Jul 14, 2021 (view filing)Jul 122 daysRogers Erica J.President and CEOSSale−11.0K$46.25−$508.8K−7.7%132.0K after
Jul 6, 2021 (view filing)Jul 15 daysDavis Andrew S.Chief Commercial OfficerSSale−6.32K$48.06−$303.9K−16.6%31.7K after